Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea

Published:2017 Issue:2 Volume:80 Page:143
ISSN:1738-3536
Container-title:Tuberculosis and Respiratory Diseases
language:en
Short-container-title:Tuberc Respir Dis

Author:

Kang Bo Hyoung¹,Jo Kyung-Wook²,Shim Tae Sun²

Affiliation:

1. Department of Pulmonary and Critical Care Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea.

2. Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Funder

Daichi Sankyo Korea

Publisher

The Korean Academy of Tuberculosis and Respiratory Diseases

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Link

https://synapse.koreamed.org/pdf/10.4046/trd.2017.80.2.143

Reference31 articles.

1. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

2. Toxic Hepatitis with Isoniazid and Rifampin

3. Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis

4. Adverse reactions to first-line antituberculosis drugs

5. Fluoroquinolones as Chemotherapeutics Against Mycobacterial Infections

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Drug Reactions with First-Line and Second-Line Drugs in Treatment of Tuberculosis;Annals of the National Academy of Medical Sciences (India);2021-01

2. Age-stratified anti-tuberculosis drug resistance profiles in South Korea: a multicenter retrospective study;BMC Infectious Diseases;2020-06-23

3. Adverse drug reactions in tuberculosis and management;Indian Journal of Tuberculosis;2019-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3